This site is a comprehensive resource for biotech enthusiasts, including investors, researchers, media, etc. You'll find information about drug discovery and development, the FDA approval process, and loads of links and information about specific drugs and biotech companies.
BiotechDueDiligence's Latest Posts
How even a ridiculous, fake tweet can move stocks these daysBrad Loncar (Loncar Blog) $ICPTDIY Diagnosis: How an Extreme Athlete Uncovered Her Genetic FlawEd Yong (Pacific Standard)The Cancer Drug That Almost Wasn'tScience. $PFEAlso see companion write-up from In the Pipeline blog.The rise of the seemingly serious but “just for entertainment purposes” medical appBrian Dolan (Mobi Health News)Coke Confronts its Big Fat ProblemClaire Suddath and Duane Stanford (Bloomberg […]
Ebola OutbreakSpecial feature / homepage from the New England Journal of Medicine. You can also check out the FDA webpage dedicated to the Ebola crisis. $TKMR $SRPTMicrobiology: Microbiome science needs a healthy dose of skepticismWilliam Hanage. Nature.Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older AdultsDiazGranados et al. New England Journal of Medicine. $SNYDesign of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI […]
I am pleased to report that the Pipelines page has been completely updated over the past couple days. This feature highlights the latest links and files related to clinical research and development pipeline progress for major biotech and pharmaceutical companies. More and more, I am trying to host PDF files of the pipeline status rather than just a website link, in order to better preserve the historical context. I hope you find this resource useful and I welcome any feedback. […]
Cancer: Unpronounceable Drugs, Incomprehensible PricesPeter Bach (Forbes) $PFE Xalkori, $NVS ZykadiaIncomprehensible Drug Prices? Think AgainDerek Lowe (In the Pipeline)9 Free Tools Regulatory Professionals Can use to Monitor the Regulatory LandscapeAlec Gaffney (RAPS Regulatory Focus)Spotting Cancer in a Vial of BloodAntonio Regalado (MIT Technology Review)While Protesters Rage Against Tech Giants, Biotech Drives Quietly ByAlex Lash (Xconomy)Flatley's Law: How One Company Is Creating Medic […]
Who's Afraid of Peer Review?John Bohannon. Science.New Expensive Treatments for Hepatitis C InfectionTroyen Brennan. Journal of the American Medical Association. $GILDNiacin and HDL Cholesterol — Time to Face FactsDonald Lloyd-Jones. New England Journal of Medicine.Group seeks standardization for what clinical trials must measureAmanda Keener. Nature Medicine.Emergence of Zaire Ebola Virus Disease in Guinea — Preliminary ReportSylvain Baize et al. NEJM. $TKMR $SRPTThe strain […]
Log in to leave a comment